Overview

Essential resource for the fight against emerging infectious diseases Incidences such as the 2014 Ebola epidemic in West Africa and the 2015 appearance of Zika in Brazil provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and threaten global health. The challenge facing infectious disease specialists and public health professionals is to improve and find new diagnostic, therapeutic, and prevention strategies. The editors of the 10th installment of the Emerging Infections series have compiled the perspectives of leading infectious disease experts into 22 chapters that provide important updates on a broad range of emerging and reemerging bacterial, viral, parasitic, and fungal infectious diseases in the United States and globally. In addition to focusing on MERS, Ebola virus disease, chikungunya, and Zika virus disease, Emerging Infections 10 explores the global threat of antimicrobial resistance in reviews on carbapenem-resistant Enterobacteriaceae, multiply-resistant gonococcal infections, non-typhoidal Salmonella infections, and artemisinin-resistant Plasmodium falciparum malaria. Topics include both recently- and long-recognized diseases that pose challenges for the clinical, laboratory, research, public health, and animal health communities. Emerging Infections 10 presents new and emerging strategies to prevent, control, and eradicate infectious diseases and guides readers to the primary literature where they can explore individual topics in greater depth. This book is a valuable reference for professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

Full Product Details

9781555819446

Table of Contents

Reviews

The renowned editors and the authors they enlisted teach us about microbial threats in our rapidly changing world. From frogs to people, from viruses to fungi, they detail compelling stories about urgent problems and suggest solutions. Emerging Infections 10 is an education at the front-lines of a perennial struggle. - Martin J. Blaser, M.D., Director, Human Microbiome Program, New York Universitym, Author of Missing Microbes In keeping with the longstanding tradition of this series, the 10th edition of Emerging Infections continues with timely updates of the newest information on the ever changing landscape of new infections of public health importance. - David C. Hooper, MD, Professor of Medicine, Harvard Medical School; Chief, Infection Control Unit and Associate Chief, Division of Infectious Diseases, Massachusetts General Hospital

-The renowned editors and the authors they enlisted teach us about microbial threats in our rapidly changing world. From frogs to people, from viruses to fungi, they detail compelling stories about urgent problems and suggest solutions. Emerging Infections 10 is an education at the front-lines of a perennial struggle.- ─ Martin J. Blaser, M.D., Director, Human Microbiome Program, New York Universitym, Author of Missing Microbes -In keeping with the longstanding tradition of this series, the 10th edition of Emerging Infections continues with timely updates of the newest information on the ever changing landscape of new infections of public health importance.- ─ David C. Hooper, MD, Professor of Medicine, Harvard Medical School; Chief, Infection Control Unit and Associate Chief, Division of Infectious Diseases, Massachusetts General Hospital

The renowned editors and the authors they enlisted teach us about microbial threats in our rapidly changing world. From frogs to people, from viruses to fungi, they detail compelling stories about urgent problems and suggest solutions. Emerging Infections 10 is an education at the front-lines of a perennial struggle. Martin J. Blaser, M.D., Director, Human Microbiome Program, New York Universitym, Author of Missing Microbes In keeping with the longstanding tradition of this series, the 10th edition of Emerging Infections continues with timely updates of the newest information on the ever changing landscape of new infections of public health importance. David C. Hooper, MD, Professor of Medicine, Harvard Medical School; Chief, Infection Control Unit and Associate Chief, Division of Infectious Diseases, Massachusetts General Hospital The renowned editors and the authors they enlisted teach us about microbial threats in our rapidly changing world. From frogs to people, from viruses to fungi, they detail compelling stories about urgent problems and suggest solutions. Emerging Infections 10 is an education at the front-lines of a perennial struggle. â Martin J. Blaser, M.D., Director, Human Microbiome Program, New York Universitym, Author of Missing Microbes In keeping with the longstanding tradition of this series, the 10th edition of Emerging Infections continues with timely updates of the newest information on the ever changing landscape of new infections of public health importance. â David C. Hooper, MD, Professor of Medicine, Harvard Medical School; Chief, Infection Control Unit and Associate Chief, Division of Infectious Diseases, Massachusetts General Hospital -The renowned editors and the authors they enlisted teach us about microbial threats in our rapidly changing world. From frogs to people, from viruses to fungi, they detail compelling stories about urgent problems and suggest solutions. Emerging Infections 10 is an education at the front-lines of a perennial struggle.- â Martin J. Blaser, M.D., Director, Human Microbiome Program, New York Universitym, Author of Missing Microbes -In keeping with the longstanding tradition of this series, the 10th edition of Emerging Infections continues with timely updates of the newest information on the ever changing landscape of new infections of public health importance.- â David C. Hooper, MD, Professor of Medicine, Harvard Medical School; Chief, Infection Control Unit and Associate Chief, Division of Infectious Diseases, Massachusetts General Hospital

Author Information

W. Michael Scheld, MD, is the Bayer-Gerald Mandell Professor of Infectious Diseases, Professor of Medicine, Clinical Professor of Neurosurgery, and Director of the Center for Global Health at the University of Virginia School of Medicine. Dr. Scheld's research includes the molecular pathogenesis and pathophysiology of bacterial infections, anti-inflammatory mechanisms of adenosine receptor subtype agonists and antagonists, antimicrobial resistance, sepsis and septic shock, anthrax, and international health issues including HIV/AIDS in Africa. James M. Hughes, MD, is Professor of Medicine and Public Health with joint appointments in the School of Medicine (Infectious Diseases) and the Rollins School of Public Health (Global Health) at Emory University and Co-Director of the Emory Antibiotic Resistance Center. Dr. Hughes' research includes emerging and reemerging infectious diseases; antimicrobial resistance; healthcare-associated infections; vectorborne and zoonotic diseases; foodborne and waterborne diseases; vaccine-preventable diseases; rapid detection of and response to infectious diseases and bioterrorism; and strategies for strengthening public health capacity at the local, national, and global levels.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available